Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2

Mostrar otras versiones (1)

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concerns (VOCs) continue to emerge, cross-neutralizing antibody responses become key toward next-generation design of a more universal COVID-19 vaccine. By analyzing published data from the literature, we report here that th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Meng, Wang, Yiquan, Lv, Huibin, Tan, Timothy J.C., Wilson, Ian A., Wu, Nicholas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2022
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606039/
https://www.ncbi.nlm.nih.gov/pubmed/36335937
http://dx.doi.org/10.1016/j.celrep.2022.111650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606039/
https://www.ncbi.nlm.nih.gov/pubmed/36335937
http://dx.doi.org/10.1016/j.celrep.2022.111650

Ejemplares similares